A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
Status:
Recruiting
Trial end date:
2026-01-26
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective, open-label, interventional umbrella study to evaluate the
efficacy and safety of targeted therapies guided by molecular subtypes in patients with
relasped or refractory peripheral T-cell lymphoma.